India's Stempeutics seeks partner as projects advance
This article was originally published in Scrip
Executive Summary
Stempeutics Research, an Indian stem cell company, is hoping to rope in a strategic partner to finance its R&D, even as it remains upbeat about the prospects of ongoing trials to develop potential treatments for acute myocardial infarction and critical limb ischaemia.